Guingona, Ester S.
HRN: 23-18-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
CEFTRIAXONE 1G (VIAL)
03/13/2026
03/20/2026
IV
2 Grams
OD
Lacerated Wound, Head; TBI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: